Thyroid Cancer Coverage from Every Angle
Advertisement
Advertisement

Lori J. Wirth, MD, on Selpercatinib, Medullary Thyroid Cancer, and Diarrhea

Posted: Thursday, November 12, 2020

Lori J. Wirth, MD, of Massachusetts General Hospital, discusses the RET inhibitor selpercatinib and the serendipitous finding that, not only is it an effective treatment of medullary thyroid cancer, it also reduces the diarrhea reported by most patients with this disease.

Advertisement
Advertisement


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.